KLOW is a multi-peptide formulation combining GHK-Cu, KPV, BPC-157, and Thymosin Beta-4 Fragment (TB-500) that has been studied in preclinical in-vitro and animal models for its synergistic interactions with neuro-inflammatory cytokines, tissue repair mechanisms, and cellular migration pathways. It is used as a reference combination in comparative anti-inflammatory, extracellular matrix, and systemic recovery research. KLOW is supplied as a lyophilized research material and is studied for its compound interactions, mast cell modulation, and tissue-healing signaling characteristics under controlled experimental conditions. This product is intended for laboratory and research use only. Not for human consumption.